Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone
- PMID: 197125
- PMCID: PMC372429
- DOI: 10.1172/JCI108835
Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone
Abstract
The effects of estrogen and progesterone on uterine alpha-adrenergic receptors were investigated by direct receptor-binding studies. Immature female rabbits were primed with estrogen by intramuscular injections for 4 days. Other rabbits were primed with progesterone by injections of estrogen for 4 days followed by injections of progesterone for 4 days. The alpha adrenergic antagonist, [3H]dihydroergocryptine, was used to directly assess the number and affinity of alpha adrenergic receptors in membranes derived from estrogen-and progesterone-primed uteri. Membranes from estrogen-primed uteri contained 257 +/- 52 fmol of [3H]dihydroergocryptine-binding sites per mg protein whereas membranes from progesterone-primed uteri contained 83 +/- 11 fmol of of binding sites per mg protein. This reduction of alpha adrenergic receptor-binding sites by progesterone was statistically significant (P less than 0.02). In contrast, no significant difference in the binding site affinity was observed between the estrogen- and progesterone-primed groups. The progesterone-induced decrease in the number of uterine alpha adrenergic receptors provides a potential explanation for the reduced alpha adrenergic contractile response to epinephrine in the progesterone-primed myometrium.
Similar articles
-
Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids.Mol Pharmacol. 1981 Jul;20(1):52-8. Mol Pharmacol. 1981. PMID: 6270537 No abstract available.
-
Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.Mol Pharmacol. 1977 Mar;13(2):304-13. Mol Pharmacol. 1977. PMID: 192992 No abstract available.
-
[3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.J Pharmacol Exp Ther. 1990 May;253(2):819-24. J Pharmacol Exp Ther. 1990. PMID: 1971023
-
Hormonal regulation myometrial adrenergic responses: the receptor and beyond.J Dev Physiol. 1989 Mar;11(3):125-34. J Dev Physiol. 1989. PMID: 2553793 Review.
-
[Role of adrenergic mechanisms in the regulation of uterine contraction].Akush Ginekol (Mosk). 1984 Jul;(7):6-9. Akush Ginekol (Mosk). 1984. PMID: 6383104 Review. Russian. No abstract available.
Cited by
-
Natural progesterone and antihypertensive action.Br Med J (Clin Res Ed). 1985 Jan 5;290(6461):13-4. doi: 10.1136/bmj.290.6461.13. Br Med J (Clin Res Ed). 1985. PMID: 3917316 Free PMC article. Clinical Trial.
-
Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide.Br J Pharmacol. 1990 Jun;100(2):341-7. doi: 10.1111/j.1476-5381.1990.tb15806.x. Br J Pharmacol. 1990. PMID: 1974161 Free PMC article.
-
Oxygen consumption of oestradiol-treated rats.Pflugers Arch. 1994 Feb;426(3-4):351-3. doi: 10.1007/BF00374793. Pflugers Arch. 1994. PMID: 8183647
-
Hormonal and local regulation of uterine activity during parturition: Part II--The prostaglandin and adrenergic systems.J Endocrinol Invest. 1994 Oct;17(9):757-70. doi: 10.1007/BF03347772. J Endocrinol Invest. 1994. PMID: 7868821 Review. No abstract available.
-
Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report.Case Rep Womens Health. 2020 Apr 21;27:e00206. doi: 10.1016/j.crwh.2020.e00206. eCollection 2020 Jul. Case Rep Womens Health. 2020. PMID: 32373479 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources